Pathophysiology of chronic rhinosinusitis

Proceedings of the American Thoracic Society

Volumn 8, Issue 1, 2011, Pages 115-120

  Tomassen, Peter ^a   Van Zele, Thibaut ^a   Zhang, Nan ^a   Perez Novo, Claudina ^a   Van Bruaene, Nicholas ^a   Gevaert, Philippe ^a   Bachert, Claus ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Airway remodeling; Enterotoxins; Nasal polyps; Sinusitis; Superantigens

Indexed keywords

CHEMOKINE; CYCLOOXYGENASE 1 INHIBITOR; ENTEROTOXIN; EOSINOPHIL CATIONIC PROTEIN; EOTAXIN; EOTAXIN 2; EOTAXIN 3; GELATINASE A; GELATINASE B; ICOSANOID; IMMUNOGLOBULIN E; INTERLEUKIN 5; MATRILYSIN; MATRIX METALLOPROTEINASE; RANTES; SUPERANTIGEN; TRANSCRIPTION FACTOR GATA 3; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; VASCULAR CELL ADHESION MOLECULE 1;

AIRWAY REMODELING; ASPIRIN EXACERBATED RESPIRATORY DISEASE; BACTERIAL COLONIZATION; CELL ADHESION; CELL INFILTRATION; CHRONIC DISEASE; CHRONIC RHINOSINUSITIS; CONFERENCE PAPER; EFFECTOR CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FACE PAIN; FATTY ACID METABOLISM; FUNGUS; HEALTH CARE COST; HUMAN; HYPOSMIA; IMMUNOGLOBULIN PRODUCTION; INFLAMMATORY CELL; LYMPHOCYTIC INFILTRATION; NOSE OBSTRUCTION; NOSE POLYP; QUALITY OF LIFE; RHINORRHEA; RHINOSINUSITIS; STAPHYLOCOCCUS AUREUS; ADOLESCENT; ADULT; AGE DISTRIBUTION; CHILD; FEMALE; HOSPITALIZATION; INCIDENCE; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; REVIEW; RHINITIS; RISK FACTOR; SEX RATIO; SICKNESS IMPACT PROFILE; SINUSITIS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; CHILD; CHRONIC DISEASE; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NASAL OBSTRUCTION; NASAL POLYPS; QUALITY OF LIFE; RHINITIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SICKNESS IMPACT PROFILE; SINUSITIS; YOUNG ADULT;

EID: 79960626972     PISSN: 15463222     EISSN: 19435665     Source Type: Journal    
DOI: 10.1513/pats.201005-036RN     Document Type: Conference Paper

References (80)

1. Ray NF, Baraniuk JN, Thamer M, Rinehart CS, Gergen PJ, Kaliner M, Josephs S, Pung YH. Healthcare expenditures for sinusitis in 1996: contributions of asthma, rhinitis, and other airway disorders. J Allergy Clin Immunol 1999;103:408-414. (Pubitemid 29136293)
2. Durr DG, Desrosiers MY, Dassa C. Impact of rhinosinusitis in health care delivery: the Quebec experience. J Otolaryngol 2001;30:93-97. (Pubitemid 34272949)
3. Goetzel RZ, Hawkins K, Ozminkowski RJ, Wang S. The health and productivity cost burden of the "top 10" physical and mental health conditions affecting six large US employers in 1999. J Occup Environ Med 2003;45:5-14. (Pubitemid 36091516)
4. Kok J, Fokkens W, Bachert C, Toskala E, Jarvis D, Bousquet J, Burney P. The high prevalence of chronic rhinosinusitis in Europe: findings from the GA2LEN Questionnaire. Allergy 2009;64:1429.
5. Gevaert P, Lang-Loidolt D, Lackner A, Stammberger H, Staudinger H, Van Zele T, Holtappels G, Tavernier J, van Cauwenberge P, Bachert C. Nasal IL-5 levels determine the response to anti - IL-5 treatment in patients with nasal polyps. J Allergy Clin Immunol 2006;118:1133-1141. (Pubitemid 44666979)
6. Fokkens W, Lund V, Mullol J. European position paper on rhinosinusitis and nasal polyps 2007. Rhinol Suppl 2007;20:1-136.
7. Meltzer EO, Hamilos DL, Hadley JA, Lanza DC, Marple BF, Nicklas RA, Bachert C, Baraniuk J, Baroody FM, Benninger MS, et al. Rhinosinusitis: establishing definitions for clinical research and patient care. Otolaryngol Head Neck Surg 2004;131(6, Suppl):S1-S62. (Pubitemid 39577605)
8. Scadding GK, Durham SR, Mirakian R, Jones NS, Drake-Lee AB, Ryan D, Dixon TA, Huber PA, Nasser SM. BSACI guidelines for the management of rhinosinusitis and nasal polyposis. Clin Exp Allergy 2008;38:260-275.
9. Van Crombruggen K, Van Bruaene N, Holtappels G, Bachert C. Chronic sinusitis and rhinitis: clinical terminology "chronic rhinosinusitis" further supported. Rhinology 2010;48:54-58.
10. Van Zele T, Claeys S, Gevaert P, Van Maele G, Holtappels G, Van Cauwenberge P, Bachert C. Differentiation of chronic sinus diseases by measurement of inflammatory mediators. Allergy 2006;61:1280-1289. (Pubitemid 44465587)
11. Litvack JR, Fong K, Mace J, James KE, Smith TL. Predictors of olfactory dysfunction in patients with chronic rhinosinusitis. Laryngoscope 2008;118:2225-2230.
12. Banerji A, Piccirillo JF, Thawley SE, Levitt RG, Schechtman KB, Kramper MA, Hamilos DL. Chronic rhinosinusitis patients with polyps or polypoid mucosa have a greater burden of illness. Am J Rhinol 2007;21:19-26. (Pubitemid 46231484)
13. Dudvarski Z, Pendjer I, Djukic V, Janosevic L, Mikic A. The analysis of clinical characteristics of the chronic rhinosinusitis: complicated and uncomplicated form. Eur Arch Otorhinolaryngol 2008;265:923-927.
14. Zhang N, Van Zele T, Perez-Novo C, Van Bruaene N, Holtappels G, DeRuyck N, Van Cauwenberge P, Bachert C. Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease. J Allergy Clin Immunol 2008;122:961-968.
15. Bachert C, Gevaert P, Holtappels G, Cuvelier C, van Cauwenberge P. Nasal polyposis: from cytokines to growth. AmJ Rhinol 2000;14:279-290.
16. Stoop AE, van der Heijden HA, Biewenga J, van der Baan S. Eosinophils in nasal polyps and nasal mucosa: an immunohistochemical study. J Allergy Clin Immunol 1993;91:616-622. (Pubitemid 23062932)
17. Zhang N, Holtappels G, Claeys C, Huang G, van Cauwenberge P, Bachert C. Pattern of inflammation and impact of Staphylococcus aureus enterotoxins in nasal polyps from southern China. Am J Rhinol 2006;20:445-450. (Pubitemid 44390224)
18. Claeys S, Van Hoecke H, Holtappels G, Gevaert P, De Belder T, Verhasselt B, Van Cauwenberge P, Bachert C. Nasal polyps in patients with and without cystic fibrosis: a differentiation by innate markers and inflammatory mediators. Clin Exp Allergy 2005;35:467-472. (Pubitemid 40577239)
19. Bachert C, Wagenmann M, Hauser U, Rudack C. IL-5 synthesis is upregulated in human nasal polyp tissue. J Allergy Clin Immunol 1997;99:837-842. (Pubitemid 27280376)
20. Van Bruaene N, Perez-Novo CA, Basinski TM, Van Zele T, Holtappels G, De Ruyck N, Schmidt-Weber C, Akdis C, Van Cauwenberge P, Bachert C, et al. T-cell regulation in chronic paranasal sinus disease. J Allergy Clin Immunol 2008;121:1435-1441, 1441.e1-1441.e3.
21. Molet SM, Hamid QA, Hamilos DL. IL-11 and IL-17 expression in nasal polyps: relationship to collagen deposition and suppression by intranasal fluticasone propionate. Laryngoscope 2003;113:1803-1812. (Pubitemid 37210986)
22. Van Bruaene N, Derycke L, Perez-Novo CA, Gevaert P, Holtappels G, De Ruyck N, Cuvelier C, Van Cauwenberge P, Bachert C. TGF-β signaling and collagen deposition in chronic rhinosinusitis. J Allergy Clin Immunol 2009;124:253-259, 259.e251-259.e252.
23. 1 in nasal remodeling: differences between chronic rhinosinusitis and nasal polyposis. Am J Rhinol 2004;18:267-272.
24. Li X, Meng J, Qiao X, Liu Y, Liu F, Zhang N, Zhang J, Holtappels G, Luo B, Zhou P, et al. Expression of TGF, matrix metalloproteinases and tissue inhibitors in Chinese chronic rhinosinusitis. J Allergy Clin Immunol 2010;125:1061-1068.
25. Chen YS, Langhammer T, Westhofen M, Lorenzen J. Relationship between matrix metalloproteinases MMP-2, MMP-9, tissue inhibitor of matrix metalloproteinases-1 and IL-5, IL-8 in nasal polyps. Allergy 2007;62:66-72. (Pubitemid 44902737)
26. Watelet J-B, Bachert C, Claeys C, Van Cauwenberge P. Matrix metalloproteinases MMP-7, MMP-9 and their tissue inhibitor TIMP-1: expression in chronic sinusitis vs nasal polyposis. Allergy 2004;59:54-60. (Pubitemid 38167952)
27. Lechapt-Zalcman E, Coste A, d'Ortho MP, Frisdal E, Harf A, Lafuma C, Escudier E. Increased expression of matrix metalloproteinase-9 in nasal polyps. J Pathol 2001;193:233-241. (Pubitemid 32120085)
28. Watelet JB, Claeys C, Van Cauwenberge P, Bachert C. Predictive and monitoring value of matrix metalloproteinase-9 for healing quality after sinus surgery. Wound Repair Regen 2004;12:412-418. (Pubitemid 39007041)
29. Huvenne W, Zhang N, Tijsma E, Hissong B, Huurdeman J, Holtappels G, Claeys S, Van Cauwenberge P, Nelis H, Coenye T, et al. Pilot study using doxycycline-releasing stents to ameliorate postoperative healing quality after sinus surgery. Wound Repair Regen 2008;16:757-767.
30. Can IH, Ceylan K, Caydere M, Samim EE, Ustun H, Karasoy DS. The expression of MMP-2, MMP-7, MMP-9, and TIMP-1 in chronic rhinosinusitis and nasal polyposis. Otolaryngol Head Neck Surg 2008;139:211-215. (Pubitemid 352010414)
31. 1. J Korean Med Sci 2003;18:97-102.
32. Eisenberg G, Pradillo J, Plaza G, Lizasoain I, Moro MA. [Increased expression and activity of MMP-9 in chronic rhinosinusitis with nasal polyposis]. Acta Otorrinolaringol Esp 2008;59:444-447.
33. Bachert C, Van Bruaene N, Toskala E, Zhang N, Olze H, Scadding G, Van Drunen CM, Mullol J, Cardell L, Gevaert P, et al. Important research questions in allergy and related diseases: 3-chronic rhinosinusitis and nasal polyposis - a GALEN study. Allergy 2009;64:520-533.
34. Bachert C, Gevaert P, Holtappels G, Johansson SG, van Cauwenberge P. Total and specific IgE in nasal polyps is related to local eosinophilic inflammation. J Allergy Clin Immunol 2001;107:607-614. (Pubitemid 32397745)
35. Wertheim HF, Melles DC, Vos MC, van Leeuwen W, van Belkum A, Verbrugh HA, Nouwen JL. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis 2005;5:751-762. (Pubitemid 41688980)
36. Araujo E, Palombini BC, Cantarelli V, Pereira A, Mariante A. Microbiology of middle meatus in chronic rhinosinusitis. Am J Rhinol 2003;17:9-15. (Pubitemid 36395381)
37. Damm M, Quante G, Jurk T, Sauer JA. Nasal colonization with Staphylococcus aureus is not associated with the severity of symptoms or the extent of the disease in chronic rhinosinusitis. Otolaryngol Head Neck Surg 2004;131:200-206. (Pubitemid 39208696)
38. Van Zele T, Gevaert P, Watelet JB, Claeys G, Holtappels G, Claeys C, van Cauwenberge P, Bachert C. Staphylococcus aureus colonization and IgE antibody formation to enterotoxins is increased in nasal polyposis. J Allergy Clin Immunol 2004;114:981-983. (Pubitemid 39330280)
39. Gevaert P, Holtappels G, Johansson SG, Cuvelier C, Cauwenberge P, Bachert C. Organization of secondary lymphoid tissue and local IgE formation to Staphylococcus aureus enterotoxins in nasal polyp tissue. Allergy 2005;60:71-79.
40. Sachse F, Becker K, Rudack C. Incidence of staphylococcal colonization and of the 753Q Toll-like receptor 2 variant in nasal polyposis. Am J Rhinol Allergy 2010;24:e10-e13.
41. Niederfuhr A, Kirsche H, Deutschle T, Poppert S, Riechelmann H, Wellinghausen N. Staphylococcus aureus in nasal lavage and biopsy of patients with chronic rhinosinusitis. Allergy 2008;63:1359-1367.
42. Clement S, Vaudaux P, Francois P, Schrenzel J, Huggler E, Kampf S, Chaponnier C, Lew D, Lacroix JS. Evidence of an intracellular reservoir in the nasal mucosa of patients with recurrent Staphylococcus aureus rhinosinusitis. J Infect Dis 2005;192:1023-1028. (Pubitemid 41266799)
43. Plouin-Gaudon I, Clement S, Huggler E, Chaponnier C, Francois P, Lew D, Schrenzel J, Vaudaux P, Lacroix JS. Intracellular residency is frequently associated with recurrent Staphylococcus aureus rhinosinusitis. Rhinology 2006;44:249-254. (Pubitemid 46029235)
44. Corriveau M, Zhang N, Holtappels G, Van Roy N, Bachert C. Detection of Staphylococcus aureus in nasal tissue with peptide nucleic acid: fluorescence in situ hybridisation. Am J Rhinol Allergy 2009;23:461-465.
45. Sachse F, Becker K, von Eiff C, Metze D, Rudack C. Staphylococcus aureus invades the epithelium in nasal polyposis and induces IL-6 in nasal epithelial cells in vitro. Allergy 2010;65:1430-1437.
46. Marrack P, Kappler J. The staphylococcal enterotoxins and their relatives. Science 1990;248:705-711.
47. Fraser JD, Proft T. The bacterial superantigen and superantigen-like proteins. Immunol Rev 2008;225:226-243.
48. el-Fiky LM, Khamis N, Mostafa Bel D, Adly AM. Staphylococcal infection and toxin production in chronic rhinosinusitis. Am J Rhinol Allergy 2009;23:264-267.
49. Seiberling KA, Conley DB, Tripathi A, Grammer LC, Shuh L, Haines GK III, Schleimer R, Kern RC. Superantigens and chronic rhinosi- nusitis: detection of staphylococcal exotoxins in nasal polyps. Laryngoscope 2005;115:1580-1585. (Pubitemid 41330665)
50. Wang M, Shi P, Chen B, Zhang H, Jian J, Chen X, Wang Z, Zhang D. The role of superantigens in chronic rhinosinusitis with nasal polyps. ORL J Otorhinolaryngol Relat Spec 2008;70:97-103. (Pubitemid 351535828)
51. Gould HJ, Takhar P, Harries HE, Chevretton E, Sutton BJ. The allergic march from Staphylococcus aureus superantigens to immunoglobulin E. Chem Immunol Allergy 2007;93:106-136.
52. Bernstein JM, Ballow M, Schlievert PM, Rich G, Allen C, Dryja D. A superantigen hypothesis for the pathogenesis of chronic hyperplastic sinusitis with massive nasal polyposis. Am J Rhinol 2003;17:321-326. (Pubitemid 38128686)
53. Tripathi A, Kern R, Conley DB, Seiberling K, Klemens JC, Harris KE, Suh L, Huang J, Grammer LC. Staphylococcal exotoxins and nasal polyposis: analysis of systemic and local responses. Am J Rhinol 2005;19:327-333. (Pubitemid 41341771)
54. Conley DB, Tripathi A, Seiberling KA, Schleimer RP, Suh LA, Harris K, Paniagua MC, Grammer LC, Kern RC. Superantigens and chronic rhinosinusitis: skewing of T-cell receptor Vb-distributions in polypderived CD4+ and CD8+ T cells. Am J Rhinol 2006;20:534-539. (Pubitemid 44575721)
55. Conley DB, Tripathi A, Seiberling KA, Suh LA, Harris KE, Paniagua MC, Grammer LC, Kern RC. Superantigens and chronic rhinosinusitis II: analysis of T-cell receptor Vβ domains in nasal polyps. Am J Rhinol 2006;20:451-455. (Pubitemid 44390225)
56. Patou J, Gevaert P, Van Zele T, Holtappels G, van Cauwenberge P, Bachert C. Staphylococcus aureus enterotoxin B, protein A, and lipoteichoic acid stimulations in nasal polyps. J Allergy Clin Immunol 2008;121:110-115.
57. Conley DB, Tripathi A, Ditto AM, Reid K, Grammer LC, Kern RC. Chronic sinusitis with nasal polyps: staphylococcal exotoxin immunoglobulin E and cellular inflammation. Am J Rhinol 2004;18:273-278. (Pubitemid 39618655)
58. Tripathi A, Conley DB, Grammer LC, Ditto AM, Lowery MM, Seiberling KA, Yarnold PA, Zeifer B, Kern RC. Immunoglobulin E to staphylococcal and streptococcal toxins in patients with chronic sinusitis/nasal polyposis. Laryngoscope 2004;114:1822-1826. (Pubitemid 39332262)
59. Gevaert P. Evidence of receptor revision and class switching to IgE in nasal polyps. Presented at the Collegium Internationale Allergologicum 28th Symposium, Ischia, April 25-30, 2010.
60. Van Zele T, Gevaert P, Holtappels G, van Cauwenberge P, Bachert C. Local immunoglobulin production in nasal polyposis is modulated by superantigens. Clin Exp Allergy 2007;37:1840-1847.
61. Keith PK, Conway M, Evans S, Wong DA, Jordana G, Pengelly D, Dolovich J. Nasal polyps: effects of seasonal allergen exposure. J Allergy Clin Immunol 1994;93:567-574. (Pubitemid 24105061)
62. Nonaka M, Pawankar R, Saji F, Yagi T. Eotaxin synthesis by nasal polyp fibroblasts. Acta Otolaryngol 1999;119:816-820. (Pubitemid 30070303)
63. Beck LA, Stellato C, Beall LD, Schall TJ, Leopold D, Bickel CA, Baroody F, Bochner BS, Schleimer RP. Detection of the chemokine RANTES and endothelial adhesion molecules in nasal polyps. J Allergy Clin Immunol 1996;98:766-780. (Pubitemid 26357244)
64. Olze H, Forster U, Zuberbier T, Morawietz L, Luger EO. Eosinophilic nasal polyps are a rich source of eotaxin, eotaxin-2 and eotaxin-3. Rhinology 2006;44:145-150. (Pubitemid 43862942)
65. Yao T, Kojima Y, Koyanagi A, Yokoi H, Saito T, Kawano K, Furukawa M, Kusunoki T, Ikeda K. Eotaxin-1, -2, and -3 immunoreactivity and protein concentration in the nasal polyps of eosinophilic chronic rhinosinusitis patients. Laryngoscope 2009;119:1053-1059.
66. Hamilos DL, Leung DY, Wood R, Bean DK, Song YL, Schotman E, Hamid Q. Eosinophil infiltration in nonallergic chronic hyperplastic sinusitis with nasal polyposis (CHS/NP) is associated with endothelial VCAM-1 upregulation and expression of TNF-α. Am J Respir Cell Mol Biol 1996;15:443-450. (Pubitemid 126440570)
67. Jahnsen FL, Haraldsen G, Aanesen JP, Haye R, Brandtzaeg P. Eosinophil infiltration is related to increased expression of vascular cell adhesion molecule-1 in nasal polyps. Am J Respir Cell Mol Biol 1995;12:624-632.
68. Demoly P, Crampette L, Mondain M, Enander I, Jones I, Bousquet J. Myeloperoxidase and interleukin-8 levels in chronic sinusitis. Clin Exp Allergy 1997;27:672-675. (Pubitemid 27286900)
69. Sachse F, von Eiff C, Becker K, Steinhoff M, Rudack C. Proinflammatory Impact of Staphylococcus epidermidis on the nasal epithelium quantified by IL-8 and GRO-α responses in primary human nasal epithelial cells. Int Arch Allergy Immunol 2008;145:24-32. (Pubitemid 350275250)
70. Cervin A, Wallwork B. Macrolide therapy of chronic rhinosinusitis. Rhinology 2007;45:259-267.
71. Huvenne W, Callebaut I, Reekmans K, Hens G, Bobic S, Jorissen M, Bullens DMA, Ceuppens JL, Bachert C, Hellings PW. Staphylococcus aureus enterotoxin B augments granulocyte migration and survival via airway epithelial cell activation. Allergy 2010;65:1013-1020.
72. Szczeklik A, Nizankowska E, Duplaga M; AIANE Investigators. Natural history of aspirin-induced asthma. Eur Respir J 2000;16:432-436.
73. Stevenson DD, Szczeklik A. Clinical and pathologic perspectives on aspirin sensitivity and asthma. J Allergy Clin Immunol 2006;118:773-786; quiz 787-778.
74. Suh YJ, Yoon SH, Sampson AP, Kim HJ, Kim SH, Nahm DH, Suh CH, Park HS. Specific immunoglobulin E for staphylococcal enterotoxins in nasal polyps from patients with aspirin-intolerant asthma. Clin Exp Allergy 2004;34:1270-1275. (Pubitemid 39093068)
75. Perez-Novo CA, Kowalski ML, Kuna P, Ptasinska A, Holtappels G, van Cauwenberge P, Gevaert P, Johannson S, Bachert C. Aspirin sensitivity and IgE antibodies to Staphylococcus aureus enterotoxins in nasal polyposis: studies on the relationship. Int Arch Allergy Immunol 2004;133:255-260. (Pubitemid 38529218)
76. Perez-Novo CA, Watelet JB, Claeys C, Van Cauwenberge P, Bachert C. Prostaglandin, leukotriene, and lipoxin balance in chronic rhinosinusitis with and without nasal polyposis. J Allergy Clin Immunol 2005;115:1189-1196. (Pubitemid 40824588)
77. 2synthesis, growth, and migration in nasal tissue fibroblasts. J Infect Dis 2008;197:1036-1043.
78. Ebbens FA, Georgalas C, Fokkens WJ. Fungus as the cause of chronic rhinosinusitis: the case remains unproven. Curr Opin Otolaryngol Head Neck Surg 2009;17:43-49.
79. Van Zele T, Vaneechoutte M, Holtappels G, Gevaert P, van Cauwenberge P, Bachert C. Detection of enterotoxin DNA in Staphylococcus aureus strains obtained from the middle meatus in controls and nasal polyp patients. Am J Rhinol 2008;22:223-227. (Pubitemid 351863569)
80. Kern RC, Conley DB, Walsh W, Chandra R, Kato A, Tripathi-Peters A, Grammer LC, Schleimer RP. Perspectives on the etiology of chronic rhinosinusitis: an immune barrier hypothesis. Am J Rhinol 2008;22:549-559.